Abstract library

509 results for "endoscopic full thickness resection".
#1819 Initial Experience of a Novel Endoscopic Full Thickness Resection Device (FTRD) for the Treatment of Rectal Neuroendocrine Tumours
Introduction: Standard endoscopic resection of rectal NETs is often associated with histological incomplete excision due to submucosal position within the bowel. Endoscopic full thickness resection may allow early definitive management.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: PRRT-Ablative therapies- Endoscopic treatment, surgical treatment
Presenting Author: John Knight
Authors: Fong M, Ramsey E, Boger P, Ellis R, ...
#2714 The Clinical Outcome of Non-Curative Resection of Small Rectal Neuroendocrine Tumours
Introduction: Small rectal NETs are thought to be less aggressive and relatively benign. However, lymphovascular invasion(LVI) or positive margin after endoscopic resection(ER) was noticed in small rectal NETs.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Medical treatment - others, not specified
Presenting Author: Haiyi Hu
Authors: Hu H, Li R, Xu R, Zhang S, ...
#421 Pelvic Carcinoid Tumor Recurrence Treated by Laparosocopic Ultrasonography Guided Laparoscopic Resection
Introduction: Minute retroperitoneal carcinoid tumor recurrences may be difficult to locate during surgery. A laparoscopic approach to re-resection is further hampered by the lack of tactile sense. Laparoscopic Ultrasonography (LUS) is a minimally invasive method which may compensate for the lack of palpation during laparoscopic surgery, and LUS allows for an evaluation of lesions beneath the visible surfaces. LUS is used in the pretherapeutic staging of upper GI tract cancer, and LUS can identify - and if necessary also biopsy - lesions less than 10 mm in diameter.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Dr. Henning O Nielsen
Authors: Nielsen H O, Mortensen M B, ...
#2077 Linked Colour Imaging Increases the Diagnostic Yield of Type 1 Gastric Carcinoids
Introduction: Type 1 Gastric carcinoid tumours (GCTs) are the most common neuroendocrine tumours of the stomach. Endoscopic diagnosis of Type 1 GCTs remains a challenge. White light endoscopy (WLE) and Narrow Band Imaging (NBI) have failed to demonstrate reliable endoscopic signs of carcinoid.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Imaging and Interventions (radiology, endoscopy)
Presenting Author: Dr Raj Srirajaskanthan
#1716 Trans-Anal Minimally Invasive Surgery (TAMIS) for Completion Local Excision of Well-Differentiated Rectal Neuroendocrine Tumours.
Introduction: Rectal NETs (R-NETs) <2cm are often amenable to endoscopic resection, but initial resections are often incomplete, and extended monitoring or radical surgery may then be required. Trans-anal minimally invasive surgery (TAMIS) allows resection of rectal tumours while reducing surgical morbidity. Data on its use in R-NETs is scant.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Surgical treatment
Presenting Author: Dr David Chan
Authors: Chan D, Law C, Hallet J, Singh S, ...
Keywords: TAMIS
#2709 Endoscopic Management and Outcomes of Gastro-Duodenal Neuroendocrine Tumours
Introduction: Gastric and duodenal neuroendocrine tumours are increasing in incidence. ENETS guidelines suggest endoscopic resection of type 1 gastric NENs over 10mm and consider endoscopic resection for duodenal NENs. However, the endoscopic techniques are not clearly mandated. There, is evidence to suggest endoscopic mucosal dissection has higher incidence of R0 resections compared with polypectomy or EMR alone.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Endocrine malignancies (MTC, pheochromocytoma) - diagnosis and therapy
Presenting Author: Alexandra Victor
#1519 Gastric Type I Neuroendocrine Tumors Endoscopic Treatment Options
Introduction: From 1998 till 2014 in our institution we have identified 72 patients with type I gastric neuroendocrine tumors (NET), 42 of them, without regional or distant metastases, undergone different types of endoscopic treatment.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: PRRT-Ablative therapies-Endoscopic treatment
Presenting Author: Dr. Sergey Pirogov
Keywords: gastric, NET, endoscopic, EMR, ESD, APC
#2929 Type III Gastric Neuroendocrine Neoplasms: Is Local Excision Sufficient in Selected Cases?
Introduction: As per ENETS Guidelines, patients with type III gastric neuroendocrine neoplasms (t-III g-NEN), need to undergo partial or total gastrectomy. Data for less-extensive resections are limited.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Surgical treatment and Ablative Therapies
Presenting Author: Mrs Klaire Exarchou
#2042 The Laparoscopic Approach in the Surgical Treatment of the Gastric Neuroendocrine Tumors
Introduction: The incidence of G-NETs has been increased significantly over the last decades, which seems set to continue. The treatment of gastric NETs comprises a wide range of surgical approaches alone or in combination with chemotherapy and target therapy. Laparoscopic surgery is the reasonable method of choice for the partial stomach resection as well as when the gastrectomy is needed.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Surgical treatment and Ablative Therapies
Presenting Author: MD,PhD Mykola Zubaryev
#192 Successfull Endoscopic Ultrasound-Guided Alcoholic Ablation of Insulinoma
Introduction: Insulinomas are rare endocrine tumors. The golden treatment is surgical resection. EUS-guided alcohol ablation is a new promising method to treat those patients who are not surgical candidates.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: MD Christina Schnack
Authors: schnack C, Hansen C, Nielsen H, ...